MYC alterations in multiple myeloma: Genetic insights and prognostic impact
Multiple myeloma (MM) is a hematologic malignancy with high genetic complexity. The genetic alterations that drive MM have classically been classified as primary abnormalities, including IGH translocations and hyperdiploidy, and secondary abnormalities, mainly composed of 1q gains, 17p deletions and...
Saved in:
| Main Authors: | Sara Cristóbal-Vargas, Myriam Cuadrado, Norma C Gutiérrez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558625000569 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology
by: Yingying Duan, et al.
Published: (2025-07-01) -
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
by: Arianna Giacomini, et al.
Published: (2024-11-01) -
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
by: Loris Delrieu, et al.
Published: (2024-12-01) -
Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer
by: Akiko Yamamoto, et al.
Published: (2025-04-01) -
Significance of the peripheral blood Treg/Th17 ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma and its correlation with 1q21 gain/amplification
by: Jingjing Wen, et al.
Published: (2025-05-01)